Novel therapeutic approaches for various cancer types using a modified sleeping beauty-based gene delivery system

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hong, In Sun ^a   Lee, Hwa Yong ^a   Kim, Hyun Pyo ^b  

^a Seoul National University   (South Korea)

^b Jungwon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL SPECIFICITY; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOGENE; OUTCOME ASSESSMENT; PROMOTER REGION; SLEEPING BEAUTY GENE DELIVERY SYSTEM; SUICIDE GENE; SUICIDE GENE THERAPY; TELOMERASE REVERSE TRANSCRIPTASE GENE; TRANSPOSON; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASMS; TRANSFECTION; TRANSPOSASES;

EID: 84907028470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086324     Document Type: Article

References (51)

1. Both GW (2009) Gene-directed enzyme prodrug therapy for cancer: a glimpse into the future? Discov Med 8: 97-103.
2. Rainov NG, Dobberstein KU, Sena-Esteves M, Herrlinger U, Kramm CM, et al. (1998) New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum Gene Ther 9: 1261-1273. (Pubitemid 28312891)
3. Miller AD (1992) Human gene therapy comes of age. Nature 357: 455-460.
4. Black ME, Newcomb TG, Wilson HM, Loeb LA (1996) Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A 93: 3525-3529. (Pubitemid 26125654)
5. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, et al. (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A 74: 5716-5720.
6. Sterman DH, Recio A, Vachani A, Sun J, Cheung L, et al. (2005) Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin Cancer Res 11: 7444-7453. (Pubitemid 41507705)
7. Ciceri F, Bonini C, Gallo-Stampino C, Bordignon C (2005) Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation. Cytotherapy 7: 144-149. (Pubitemid 40872749)
8. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, et al. (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A 97: 3428-3432. (Pubitemid 30183319)
9. Fischer A, Hacein-Bey-Abina S, Lagresle C, Garrigue A, Cavazana-Calvo M (2005) [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome]. Bull Acad Natl Med 189: 779-785; discussion 786-778.
10. Nair V (2008) Retrovirus-induced oncogenesis and safety of retroviral vectors. Curr Opin Mol Ther 10: 431-438.
11. Grimm D, Kleinschmidt JA (1999) Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther 10: 2445-2450. (Pubitemid 29489719)
12. Pan RY, Xiao X, Chen SL, Li J, Lin LC, et al. (1999) Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. J Virol 73: 3410-3417. (Pubitemid 29135734)
13. Cooley L, Kelley R, Spradling A (1988) Insertional mutagenesis of the Drosophila genome with single P elements. Science 239: 1121-1128. (Pubitemid 18084318)
14. Plasterk RH (1996) The Tc1/mariner transposon family. Curr Top Microbiol Immunol 204: 125-143.
15. Lohe AR, Moriyama EN, Lidholm DA, Hartl DL (1995) Horizontal transmission, vertical inactivation, and stochastic loss of mariner-like transposable elements. Mol Biol Evol 12: 62-72.
16. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510. (Pubitemid 27508239)
17. Luo G, Ivics Z, Izsvak Z, Bradley A (1998) Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A 95: 10769-10773. (Pubitemid 28413143)
18. Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, et al. (2000) Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 25: 35-41. (Pubitemid 30257033)
19. Fischer SE, Wienholds E, Plasterk RH (2001) Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci U S A 98: 6759-6764. (Pubitemid 32538290)
20. Izsvak Z, Ivics Z (2004) Sleeping beauty transposition: biology and applications for molecular therapy. Mol Ther 9: 147-156. (Pubitemid 38256540)
21. Montini E, Held PK, Noll M, Morcinek N, Al-Dhalimy M, et al. (2002) In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol Ther 6: 759-769. (Pubitemid 36054309)
22. Ortiz-Urda S, Lin Q, Yant SR, Keene D, Kay MA, et al. (2003) Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer. Gene Ther 10: 1099-1104. (Pubitemid 36850232)
23. Yant SR, Ehrhardt A, Mikkelsen JG, Meuse L, Pham T, et al. (2002) Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat Biotechnol 20: 999-1005.
24. Song J, Kim C, Ochoa ER (2009) Sleeping Beauty-mediated suicide gene therapy of hepatocellular carcinoma. Biosci Biotechnol Biochem 73: 165-168.
25. Song JS, Murase N, Demetris AJ, Michalopoulos GK, Ochoa ER (2007) Protection from acute cellular injury using Sleeping Beauty mediated telomerase gene transfer. Biochem Biophys Res Commun 363: 253-256. (Pubitemid 47484322)
26. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179. (Pubitemid 26116862)
27. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, et al. (1996) Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56: 645-650. (Pubitemid 26043667)
28. Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791.
29. Bilsland AE, Fletcher-Monaghan A, Keith WN (2005) Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy. Neoplasia 7: 1020-1029.
30. Plumb JA, Bilsland A, Kakani R, Zhao J, Glasspool RM, et al. (2001) Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene 20: 7797-7803. (Pubitemid 33121953)
31. Abdul-Ghani R, Ohana P, Matouk I, Ayesh S, Ayesh B, et al. (2000) Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. Mol Ther 2: 539-544.
32. Li S, MacLaughlin FC, Fewell JG, Gondo M, Wang J, et al. (2001) Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid. Gene Ther 8: 494-497. (Pubitemid 32266405)
33. Song JS (2004) Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer. Biosci Biotechnol Biochem 68: 1634-1639.
34. Yi X, Tesmer VM, Savre-Train I, Shay JW, Wright WE (1999) Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol 19: 3989-3997. (Pubitemid 29241973)
35. Guhaniyogi J, Brewer G (2001) Regulation of mRNA stability in mammalian cells. Gene 265: 11-23. (Pubitemid 32209246)
36. Singh Y, Palombo M, Sinko PJ (2008) Recent trends in targeted anticancer prodrug and conjugate design. Curr Med Chem 15: 1802-1826.
37. Hedley D, Ogilvie L, Springer C (2007) Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury. Nat Rev Cancer 7: 870-879. (Pubitemid 350010854)
38. Matthews T, Boehme R (1988) Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 10 Suppl 3: S490-494.
39. Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, et al. (2004) A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 31: 740-751. (Pubitemid 38647915)
40. Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389-2401.
41. Winston DJ, Wirin D, Shaked A, Busuttil RW (1995) Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 346: 69-74.
42. Portsmouth D, Hlavaty J, Renner M (2007) Suicide genes for cancer therapy. Mol Aspects Med 28: 4-41.
43. Ding S, Wu X, Li G, Han M, Zhuang Y, et al. (2005) Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122: 473-483. (Pubitemid 41127147)
44. Ivics Z, Izsvak Z (2006) Transposons for gene therapy! Curr Gene Ther 6: 593-607. (Pubitemid 44524462)
45. Balciunas D, Ekker SC (2005) Trapping fish genes with transposons. Zebrafish 1: 335-341. (Pubitemid 40428695)
46. Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436: 221-226. (Pubitemid 41021267)
47. Belur LR, Frandsen JL, Dupuy AJ, Ingbar DH, Largaespada DA, et al. (2003) Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther 8: 501-507. (Pubitemid 37161472)
48. Aronovich EL, Bell JB, Khan SA, Belur LR, Gunther R, et al. (2009) Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system. Mol Ther 17: 1136-1144.
49. Kren BT, Unger GM, Sjeklocha L, Trossen AA, Korman V, et al. (2009) Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J Clin Invest 119: 2086-2099.
50. Huang X, Guo H, Kang J, Choi S, Zhou TC, et al. (2008) Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies. Mol Ther 16: 580-589. (Pubitemid 351314999)
51. Zhou T, Kamimura K, Zhang G, Liu D (2010) Intracellular gene transfer in rats by tail vein injection of plasmid DNA. AAPS J 12: 692-698.